Targeted Therapies in Oncology
December 2
Volume: 8
Issue: 18
December 1
Volume: 8
Issue: 17
November 2 2019
Volume: 8
Issue: 16
November 1 2019
Volume: 8
Issue: 15
October 2 2019
Volume: 8
Issue: 14
October 2019
Volume: 8
Issue: 13
September 2019
Volume: 8
Issue: 12
August 2019
Volume: 8
Issue: 11
July 2019
Volume: 8
Issue: 9
July 2
Volume: 8
Issue: 10
June 2019
Volume: 8
Issue: 8
May 2019
Volume: 8
Issue: 7
April 2 2019
Volume: 8
Issue: 6
April 2019
Volume: 8
Issue: 5
March 2019
Volume: 8
Issue: 4
February 2 2019
Volume: 8
Issue: 3
February 2019
Volume: 8
Issue: 2
January 2019
Volume: 8
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
5